c-erbB-2 Expression and Response to Adjuvant Therapy in Women with Node-Positive Early Breast Cancer
1994 · New England Journal of Medicine · 968 citations
https://doi.org/10.1056/nejm199405053301802
H
Hyman B. Muss
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
5
Papers
173
Citations
4
h-index
4
i10-index
Hyman B. Muss is an academic researcher from University of Vermont Medical Center. The author has contributed to research in topics: Epilepsy research and treatment & Cancer Immunotherapy and Biomarkers & Breast Cancer Treatment Studies. The author has an h-index of 4, co-authored 5 publications.
Papers by this author
worksComing of Age: Breast Cancer in Seniors
2010 · The Oncologist · 49 citations
https://doi.org/10.1634/theoncologist.2010-s5-57
Targeted Therapy for Metastatic Breast Cancer
2006 · New England Journal of Medicine · 22 citations
https://doi.org/10.1056/nejme068260
Cyclin D-1, Interleukin-6, HER-2/neu, Transforming Growth Factor Receptor-II and Prediction of Relapse in Women with Early Stage, Hormone Receptor-Positive Breast Cancer Treated with Tamoxifen
2007 · The Breast Journal · 13 citations
https://doi.org/10.1111/j.1524-4741.2007.00440.x
Lumpectomy Plus Tamoxifen With or Without Irradiation in Women Age 70 Years or Older With Early Breast Cancer: Long-Term Follow-Up of CALGB 9343
2013 · Journal of Clinical Oncology · 1,266 citations
https://doi.org/10.1200/jco.2012.45.2615
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat